ELMD Electromed

Electromed, Inc. Introduces Expanded SmartVest® Garment and SmartVest SQL® Generator Colors to Product Line

Electromed, Inc. (NYSE MKT:ELMD) today announced the expansion of its SmartVest SQL Airway Clearance System product line to include new SmartVest garment and SQL generator colors, offering patients with chronic impaired airway clearance more opportunities to personalize their HFCWO therapy experience. The expanded SmartVest garment and SQL generator colors will debut at the North American Cystic Fibrosis Conference in Orlando, Florida, October 27 – 29, 2016.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161026005858/en/

SmartVest® SQL® Airway Clearance System (Photo: Business Wire)

SmartVest® SQL® Airway Clearance System (Photo: Business Wire)

  • SmartVest garment. Now in seven designs, including green camouflage, pink camouflage, and black, the SmartVest features Velcro-like closures, soft-touch fabric, and a single-hose design to make treatment easy and comfortable.
  • SmartVest SQL generator. The lightest HFCWO generator on the market is now available in four unique colors to fit a patient’s personal style: blue, red, bright blue, and gray.

“The SmartVest and SQL color expansion provides greater customization of one’s HFCWO therapy to promote patient satisfaction, which ultimately encourages therapy adherence,” commented Kathleen Skarvan, President and Chief Executive Officer of Electromed. “We’re proud to stand by our commitment to continued innovation by delivering market-driven HFCWO therapy solutions.”

With the expansion to seven garment colors and four generator enclosure colors, patients receive a greater opportunity to uniquely customize their SmartVest system. Higher personalization can positively influence satisfaction with therapy and may improve adherence, along with the SmartVest’s ease of use, ergonomic comfort, and lifestyle convenience. The new color selection is marketed for domestic homecare use only. The SmartVest system is designed to promote airway clearance and enhance bronchial drainage through high frequency chest wall oscillation (HFCWO), a proven clinical therapy that helps clear the lungs of excess secretions, reducing the risk of respiratory infections and hospitalizations. Airway clearance therapies must be consistently followed to have their intended benefit, and as with any treatment, poor adherence can compromise its effectiveness.

About Electromed, Inc.

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota and founded in 1992. Further information about the Company can be found at www.smartvest.com.

EN
26/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Electromed

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Electromed, Inc. Schedules its Second Quarter Fiscal 2022 Financial Re...

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on Tuesday, February 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (877) 407-0789 (Domestic) (201) 689-8562 (International) The live conference call we...

 PRESS RELEASE

Electromed, Inc. to Participate in the Sidoti December Virtual Micro C...

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti December Virtual Micro Cap Investor Conference on December 8-9, 2021. Management will be available for one-on-ones throughout both days. Below are the details for Electromed’s group presentation: Sidoti December Virtual Micro Cap Investor Conference Date: Wednesday, Dece...

 PRESS RELEASE

Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2021 (“Q1 FY 2022”). Q1 FY 2022 Highlights Net revenue increased 25.0% to $10.0 million, from $8.0 million for the three months ended September 30, 2020 (“Q1 FY 2021”), driven by 24.4% home care revenue growth and 61.5% institutional revenue growth. Gross profit percentage increased to 77.0% of net revenue, from 76.8% of net revenue in Q1 FY 2021. The inc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch